Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal hypertension.

Guadalupe Garcia-Tsao1

  • 1Section of Digestive Diseases, Yale University School of Medicine and Connecticut VA, Healthcare System, New Haven, 06510, USA. guadalupe.garcia-tsao@yale.edu

Current Opinion in Gastroenterology
|March 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice.

Gut microbes·2026
Same author

Frailty Increases Hospitalization Rates in an Ambulatory Cohort of Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease 3 Prospective Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Variceal hemorrhage in cirrhosis.

Expert review of gastroenterology & hepatology·2026
Same author

The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices.

Hepatology communications·2026
Same author

Biomarkers of inflammation and risk of adverse events in patients with cirrhosis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026

Recent advances in managing portal hypertension complications are reviewed. Key findings include new treatments for varices, ascites, and hepatic encephalopathy, improving patient outcomes.

Area of Science:

  • Hepatology and Gastroenterology
  • Clinical Medicine

Background:

  • Portal hypertension is a serious complication of liver disease.
  • Its management involves addressing factors like intrahepatic vascular resistance and splanchnic vasodilatation.

Purpose of the Study:

  • To review significant advances in the pathophysiology, diagnosis, and management of portal hypertension complications over the past year.
  • To highlight recent experimental studies and clinical findings.

Main Methods:

  • Review of experimental studies targeting factors contributing to portal hypertension.
  • Analysis of recent diagnostic and management strategies for portal hypertension complications.
  • Inclusion of prospective studies and meta-analyses.

Main Results:

Related Experiment Videos

  • Advances in understanding and managing varices, including prophylaxis and treatment of bleeding.
  • New insights into ascites and hepatorenal syndrome management.
  • Updated approaches for spontaneous bacterial peritonitis and hepatic encephalopathy.

Conclusions:

  • Beta-blockers show promise in preventing varices.
  • Combined endoscopic variceal ligation and nadolol effectively prevent recurrent variceal bleeding.
  • Large-volume paracentesis and transjugular intrahepatic portosystemic shunt are compared for refractory ascites.